United for Medical Research

United for Medical Research
Name	United for Medical Research
Founded	2010
Type	Coalition
Focus	Biomedical research advocacy
Location	Washington, D.C.

United for Medical Research is a coalition of leading research institutions, patient advocacy groups, and private industry partners dedicated to advocating for robust, sustained federal investment in the National Institutes of Health. Formed in 2010, the alliance works to educate policymakers and the public on the critical role of NIH funding in driving medical innovation, improving public health, and strengthening the U.S. economy. Its advocacy is centered on securing predictable and significant budget increases for the National Institutes of Health to accelerate the pace of discovery across a wide spectrum of diseases and conditions.

Overview

The coalition operates primarily in Washington, D.C., engaging with members of the United States Congress and officials within the Executive Office of the President, including the Office of Management and Budget. Its mission is to ensure that the National Institutes of Health receives the resources necessary to maintain the United States' global leadership in biomedical science. The group emphasizes the tangible outcomes of NIH investment, such as the development of new vaccines, cancer therapies, and advancements in genomics, while also highlighting the economic benefits, including job creation in the biotechnology sector and support for academic research hubs like the Massachusetts Institute of Technology and Stanford University.

History

United for Medical Research was established in 2010, a period following the significant one-time infusion of funds from the American Recovery and Reinvestment Act of 2009. The coalition emerged in response to concerns about the sustainability of federal research support and the potential for declining investment to stall progress. Founding members included prominent entities from the pharmaceutical industry, patient communities, and academic research centers. A key early focus was advocating for the 21st Century Cures Act, which aimed to accelerate medical product development. The coalition's advocacy efforts have consistently targeted the annual appropriations process for the Departments of Labor, Health and Human Services, and Education.

Key advocacy areas

The organization's advocacy is multifaceted, focusing on both the magnitude and stability of funding for the National Institutes of Health. A primary goal is securing annual budget increases that outpace inflation to expand the agency's capacity. It also champions specific, high-impact research initiatives, such as the Cancer Moonshot, the Brain Research Through Advancing Innovative Neurotechnologies Initiative, and the All of Us Research Program. The coalition actively opposes proposals that would cap or reduce discretionary spending for non-defense programs, arguing such measures would severely harm long-term research projects. It also advocates for policies that reduce administrative burdens on researchers at institutions like the Johns Hopkins University.

Member organizations

The coalition brings together a diverse array of stakeholders from across the biomedical research ecosystem. Its membership includes premier research universities and hospitals such as the University of Pennsylvania, the Mayo Clinic, and Duke University. Patient advocacy groups like the American Heart Association and the Alzheimer's Association are also key members, representing the voice of those awaiting new treatments. Private sector partners have included major life science companies like Pfizer and Merck & Co., as well as broader industry representatives like the Biotechnology Innovation Organization. This unified front demonstrates the widespread economic and societal support for sustained NIH investment.

Policy impact

United for Medical Research has been instrumental in several significant policy victories affecting National Institutes of Health funding. The coalition's persistent advocacy contributed to the passage of the 21st Century Cures Act in 2016, which provided additional mandatory funding for key NIH initiatives. It has also played a crucial role in securing substantial annual appropriations increases during critical budget cycles, often working in concert with other advocacy groups like Research!America and the Ad Hoc Group for Medical Research. Testimony from coalition members before committees like the Senate Appropriations Committee has provided compelling, data-driven arguments for investment, influencing lawmakers from both major political parties.

Funding initiatives

The coalition advocates for both core National Institutes of Health appropriations and specific, targeted research programs. It strongly supports the NIH's central role in funding investigator-initiated research through its various institutes, such as the National Cancer Institute and the National Institute of Allergy and Infectious Diseases. Beyond base funding, United for Medical Research champions special initiatives with focused goals, including the Precision Medicine Initiative and efforts to combat the opioid epidemic. The group also highlights the importance of funding for training the next generation of scientists through programs supported by the National Science Foundation and within academic medical centers nationwide, ensuring a robust pipeline for future discovery.

Category:Medical research organizations Category:Health advocacy groups in the United States Category:Organizations based in Washington, D.C.